Research study on the treatment patterns of gastrointestinal stromal tumor (GIST) using the claims database
Not Applicable
- Conditions
- Gastrointestinal stromal tumor (GIST)
- Registration Number
- JPRN-UMIN000054074
- Lead Sponsor
- TAIHO PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1847
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a record of antitumor drug prescription other than GIST drugs, at least 60 days before the first prescription of GIST drugs Patients who have a history of radical surgery for GIST, who have received Imatinib as the first prescription, and who have not received any GIST drugs after the completion of Imatinib treatment (adjuvant therapy period)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method